Clover Health Investments, Corp.
General ticker "CLOV" information:
- Sector: Health Care
- Industry: Medical - Healthcare Plans
- Capitalization: $1.6B (TTM average)
Clover Health Investments, Corp. does not follow the US Stock Market performance with the rate: -23.3%.
Estimated limits based on current volatility of 3.6%: low 1.99$, high 2.13$
Factors to consider:
- Total employees count: 570 (+3.3%) as of 2024
- Top business risk factors: Economic downturns and volatility, Regulatory and compliance, Market volatility, Service disruptions, Security breaches
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [2.20$, 3.91$]
- 2026-12-31 to 2027-12-31 estimated range: [2.29$, 4.05$]
Financial Metrics affecting the CLOV estimates:
- Positive: with PPE of -38.5 at the end of fiscal year the price was neutral
- Negative: Operating cash flow per share per price, % of -5.15 <= 0.01
- Positive: -4.75 < Operating profit margin, % of -4.26
- Positive: -0.01 < Industry operating cash flow per share per price (median), % of 5.10
- Positive: Industry earnings per price (median), % of 5.08 > 4.49
- Positive: 42.68 < Shareholder equity ratio, % of 57.06 <= 64.29
- Positive: Inventory ratio change, % of 0 <= 0
Short-term CLOV quotes
Long-term CLOV plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1,260.54MM | $1,371.13MM | $1,924.31MM |
| Operating Expenses | $1,465.87MM | $1,416.88MM | $2,009.84MM |
| Operating Income | $-205.33MM | $-45.75MM | $-85.53MM |
| Non-Operating Income | $-4.82MM | $-0.52MM | $-0.02MM |
| Interest Expense | $0.01MM | $0.00MM | $0.00MM |
| Income(Loss) | $-210.15MM | $-46.27MM | $-85.55MM |
| Other Income(Loss) | $0.00MM | $3.26MM | $0.00MM |
| Profit(Loss)* | $-213.36MM | $-39.75MM | $-85.55MM |
| Stockholders Equity | $286.39MM | $341.14MM | $308.70MM |
| Assets | $570.67MM | $580.74MM | $541.01MM |
| Operating Cash Flow | $-144.66MM | $34.84MM | $-66.93MM |
| Capital expenditure | $0.58MM | $1.56MM | $2.04MM |
| Investing Cash Flow | $140.01MM | $0.56MM | $4.08MM |
| Financing Cash Flow | $-5.07MM | $-17.36MM | $-53.38MM |
| Earnings Per Share** | $-0.44 | $-0.08 | $-0.17 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.